Literature
Our validated and peer-reviewed in-silico platform is built on cutting-edge research from leading academic institutions. Developed over five years as part of an EU-funded consortium, the platform simulates stroke treatments using real-world clinical and imaging data.
Standing on the shoulders of academic giants
Resulting from a 5-year EU funded consortium of top universities and the largest database of stroke worldwide, we have developed an in silico trial platform to simulate stroke and its treatment. Using the clinical, imaging, vessel and thrombus characteristics , we have developed a population model that can sample virtual patients, based on certain inclusion criterion, for example age and blood pressure – just like in a randomized clinical trial. For each of these virtual patients we can simulate the thrombectomy treatment and also the brain tissue status after treatment.
Request a free consultation
Contact us to learn how our platform can help optimize your medical device development and clinical trial designs.